Hernandez AF, Green JB, Janmohamed S, DAgostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, et al
Research evidence The pivotal efficacy evidence comes from two identically designed Phase 3 randomized placebo-controlled trials run by Theratechnologies and reported by Julian Falutz and colleagues in the New England Journal of Medicine in 2007 (Falutz et al., NEJM 357:2359-2370)
PE-22-28 (10mg) is a synthetic research peptide categorized within the broader Peptides class, commonly grouped under Brain, Cognitive & Nootropic Peptides due to its application in central nervous system (CNS)-related experimental models
This highly concentrated PRP is injected into targeted areas to improve skin quality, firmness, and texture from within
Scope and research use only restrictions All 5 AMINO 1MQ materials and associated documentation supplied by Umbrella Labs are provided strictly for laboratory research and analytical workflows
